Integra LifeSciences Reports Third Quarter 2019 Financial Results
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: GlobeNewswire
Reported revenues increased 3.6% to $379.1 million; organic revenues increased 4.7% GAAP and adjusted earnings per diluted share were $(0.32) and $0.68, respectively The Company is tightening the range for its full-year reported revenue guidance and reaffirming full-year organic revenue growth guidance The Company is revising its full-year 2019 GAAP earnings per share guidance to a new range of $0.61 to $0.66 and reaffirming full-year adjusted EPS guidance PLAINSBORO, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2019. Third Quarter 2019 Highlights Reported revenues were $379.1 million, an increase of 3.6% over the third quarter of 2018, and organic revenues increased 4.7% over the prior year; Foreign currency exchange rates negatively impacted reported revenues by $2.4 million in the third quarter of 2019
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Minimally Invasive Spinal Devices Pipeline Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Competitive Landscape [Yahoo! Finance]Yahoo! Finance
- Global Wound Filler Market Set for Steady Growth, projected to Reach USD 948.7 Million by 2034 with a 4.4% of CAGR | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target raised by analysts at Citigroup Inc. from $16.00 to $22.00. They now have a "sell" rating on the stock.MarketBeat
- Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]Yahoo! Finance
IART
Earnings
- 11/4/24 - Beat
IART
Sec Filings
- 11/12/24 - Form SC
- 11/12/24 - Form SC
- 11/4/24 - Form S-8
- IART's page on the SEC website